Dow Jones Shanghai closes November 4 at 495.71 points, up 2.82%
BUX closes 1.05 percent higher at 147,607.45 points
Nikkei 225 closes 1.42% lower after sharp intraday slide
AEX closes at 1,136.29 points, up 1.30%
TAIEX Closes at 42,948.91 After 1,885-Point Intraday Swing
VIX ends November 4 at 17.89, down 14.11 percent
Dow Jones closes 3.03% higher at 53,356.12 after election relief rally
Plug Power's 11% Sector Pop Meets a $28 Million Cash Question
SpaceX's $175 Billion Question: Adam Jonas Sees the Revenue, but the Cash Comes in 2031
Gold's 3% Pop Has a Dollar Story and a Demand Story — and They Don't Match
Infineon's Factory Floor Tells a Different Story Than Its Headlines
Nvidia Slips as Washington's Shifting Winds Meet a Packed Infrastructure Calendar
Vanguard's All-World ETF Grinds Higher as Washington Gridlock Trumps AI Spending Worries
Nebius Stock: A $3.5 Billion Credit Line, a Piper Sandler Cut, and the November 12 Earnings Test
Novo Nordisk's Wegovy Pill Is Winning the Volume Battle. The 2027 Price Cut Is the War
BioNTech's Raised Guidance Only Shifts the Question to the Pipeline
SK Hynix's US Blueprint Hits a Paperwork Wall in Dalian
Micron's Slide Is a Bet on Tomorrow's Pricing Power, Not Today's Balance Sheet
Siemens Energy: A 210 MW Mexican Electrolyser and a Hokkaido Wind Pact Sit Behind the AI Sell-Off
Rheinmetall Trims 2026 Outlook as Arminius Order Slips, Setting a Lower Bar for Recovery
Palantir's Blowout Quarter Runs Into a Backlog That Refuses to Budge
Bayer's Pharma Beat Wins Two Fresh Bull Calls, but the Margin Is Only Half the Story
ASML's Slide Is a Sector Story, Not a Company Warning
Deutz Insiders Put Money Behind the Story While an Analyst Backs the Outlook
Moderna's Pipeline Wins Are Piling Up — But the November 6 Balance Sheet Is the Real Verdict
Vonovia's Disposal Engine Becomes the Real Gauge of Its Balance-Sheet Repair
Novo Nordisk's Oral Wegovy Clears Its First Hurdle — Now Comes the Price Test
BioNTech's Raised Guidance Draws the Eye, but the Pipeline Still Has to Earn the Re-rating
Silver's 4% Rebound Masks a Deeper Debate: UBS Sees $70, China's Solar Sector Says Otherwise
Rheinmetall Cuts 2026 Guidance as Artillery Deliveries Slip Into Next Year
Lenzing's Shareholder Register Is Clear — Its Earnings Picture Is Anything But
Gold's Dollar-Driven Bounce Masks a Two-Speed Buyer Base
Evonik's 40% Earnings Surge Draws Two Hold Ratings and Only One Higher Target